Patents by Inventor Chinthalapally V. Rao

Chinthalapally V. Rao has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Licofelone derivatives and methods of use
    Patent number: 10206904
    Abstract: Derivatives of licofelone for the treatment of chronic inflammatory diseases and epithelial cancers associated with chronic inflammation are disclosed. The agents target mPGES-1 and 5-LOX.
    Type: Grant
    Filed: July 13, 2016
    Date of Patent: February 19, 2019
    Assignee: The Board of Regents of the University of Oklahoma
    Inventors: Chinthalapally V. Rao, Naveena B. Janakiram, Hariprasad Gali, Altaf Mohammed, Gopal Pathuri
  • LICOFELONE DERIVATIVES AND METHODS OF USE
    Publication number: 20180207129
    Abstract: Derivatives of licofelone for the treatment of chronic inflammatory diseases and epithelial cancers associated with chronic inflammation are disclosed. The agents target mPGES-1 and 5-LOX.
    Type: Application
    Filed: July 13, 2016
    Publication date: July 26, 2018
    Inventors: Chinthalapally V. Rao, Naveena B. Janakiram, Hariprasad Gali, Alaf Mohammed, Gopal Pathuri
  • Inhibitors of inducible nitric oxide synthase for chemoprevention and treatment of cancers
    Patent number: 7012098
    Abstract: Agents and methods for chemoprevention and treatment of neoplasia are described, the agents including a selective inhibitor of inducible nitric oxide synthase and a combination of a selective inhibitor of inducible nitric oxide synthase and an inhibitor of cylcooxygenase-2 in a pharmaceutical composition. The agents and methods are used for chemoprevention and treatment of neoplasia including colorectal cancer and other cancers affecting epithelial cells throughout the body. The agents can also be used to treat the fibrosis that occurs with radiation therapy, as well as adenomatous polyps, including those with familial adenomatous polyposis (FAP).
    Type: Grant
    Filed: September 24, 2001
    Date of Patent: March 14, 2006
    Assignee: Pharmacia Corporation
    Inventors: Pamela T. Manning, Jane R. Connor, Karen Seibert, Chinthalapally V. Rao, Bandaru S. Reddy
  • Agents and methods for treatment of cancer
    Publication number: 20030013702
    Abstract: Agents and methods for chemoprevention and treatment of neoplasia are described, the agents including a selective inhibitor of inducible nitric oxide synthase and a combination of a selective inhibitor of inducible nitric oxide synthase and an inhibitor of cylcooxygenase-2 in a pharmaceutical composition. The agents and methods are used for chemoprevention and treatment of neoplasia including colorectal cancer and other cancers affecting epithelial cells throughout the body. The agents can also be used to treat the fibrosis that occurs with radiation therapy, as well as adenomatous polyps, including those with familial adenomatous polyposis (FAP).
    Type: Application
    Filed: September 24, 2001
    Publication date: January 16, 2003
    Inventors: Pamela T. Manning, Jane R. Connor, Karen Seibert, Chinthalapally V. Rao, Bandaru S. Reddy